美国食品和药物管理局后来澄清了它只被批准用于一种罕见的疾病, 而没有证据表明有自闭症. Trump and Kennedy pushed unproven leucovorin for autism, causing a 71% prescription surge; FDA later clarified it's only approved for a rare condition with no evidence for autism.

在2025年,特朗普总统和卫生部长肯尼迪小将白素推广为潜在的自闭症治疗方法,导致儿童处方增加了71%. In 2025, President Trump and HHS Secretary Robert F. Kennedy Jr. promoted leucovorin as a potential autism treatment, triggering a 71% rise in prescriptions for children. 美国食品和药物管理局后来澄清了该药只能用于治疗脑部叶酸缺乏症,这是一个罕见的疾病,并强调没有科学证据支持其在自闭症中使用. The FDA later clarified the drug is only approved for cerebral folate deficiency, a rare condition, and emphasized there is no scientific evidence supporting its use for autism. 由于研究存在缺陷,缺乏大规模试验等问题引起了人们的担忧,医疗专家们就推广未经证实的治疗方法发出警告. The reversal followed concerns over flawed studies and lack of large-scale trials, prompting warnings from medical experts about promoting unproven therapies. 事件引发了有关政治人物对公共卫生决策的影响和基于证据的医学的重要性的问题. The episode raised questions about the influence of political figures on public health decisions and the importance of evidence-based medicine.